A specialty pharmaceutical company has secured $15 million in venture debt backing for its topical gel drug to treat the early stages of mycosis fungoides, a type of non-Hodgkin’s lymphoma. The ...

Phase II Study of Rituximab in Combination With CHOP Chemotherapy in Patients With Previously Untreated, Aggressive Non-Hodgkin’s Lymphoma PURPOSE: Establish frequency, presenting features, response ...

“Go to the emergency room,” the doctor told him after hearing of his trip and fever, rash and whole-body weakness. “You need to be seen.” By Lisa Sanders, M.D. The 57-year-old man looked up the long ...

Oncologists share the number-one sign of lymphoma that you shouldn't ignore, plus other symptoms that may signal this rare ...

What is a lymph node biopsy? A lymph node biopsy is a procedure to take out all or part of a lymph node to check it for cancer cells. (If you have tumors only outside of your lymph nodes, your ...

A new study by researchers at Karolinska Institutet and Karolinska University Hospital shows that patients diagnosed with the rare skin cancers mycosis fungoides and Sézary syndrome face a ...

Citius Oncology Inc. has commercially launched Lymphir, a treatment for Stage I–III cutaneous T-cell lymphoma, the Cranford-based firm announced Dec. 1. In August 2024, the U.S. Food and Drug ...

Relapsed or refractory cutaneous t-cell lymphoma can be treated in adults with the new FDA approval of denileukin diftitox immunotherapy. The FDA announced their approval of deileukin diftitox-cxdl ...

Health-Related Quality of Life and Financial Burden in Ethiopian Patients With Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors: A Cross-Sectional Study The global burden of lymphoma is ...